These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31025388)

  • 1. Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.
    Liang LY; Wong VW; Tse YK; Yip TC; Lui GC; Chan HL; Wong GL
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1509-1517. PubMed ID: 31025388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
    Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
    Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment.
    Liang LY; Yip TC; Lai JC; Lam AS; Tse YK; Hui VW; Chan HL; Wong VW; Wong GL
    J Viral Hepat; 2024 Dec; 31(12):808-819. PubMed ID: 39254219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
    Papatheodoridis GV; Sypsa V; Dalekos GN; Yurdaydin C; Van Boemmel F; Buti M; Calleja JL; Chi H; Goulis J; Manolakopoulos S; Loglio A; Voulgaris T; Gatselis N; Keskin O; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Idilman R; Esteban R; Janssen HLA; Berg T; Lampertico P
    J Hepatol; 2020 Jun; 72(6):1088-1096. PubMed ID: 31981727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Chan HL; Choi PC; Chan AW; Yu Z; Lai JW; Chan HY; Wong VW
    Aliment Pharmacol Ther; 2014 Jan; 39(2):197-208. PubMed ID: 24261924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
    Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
    Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
    Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
    Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
    Alonso López S; Manzano ML; Gea F; Gutiérrez ML; Ahumada AM; Devesa MJ; Olveira A; Polo BA; Márquez L; Fernández I; Cobo JCR; Rayón L; Riado D; Izquierdo S; Usón C; Real Y; Rincón D; Fernández-Rodríguez CM; Bañares R
    Hepatology; 2020 Dec; 72(6):1924-1934. PubMed ID: 33022803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
    Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
    Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.
    Jeon MY; Lee HW; Kim SU; Kim BK; Park JY; Kim DY; Han KH; Ahn SH
    Liver Int; 2018 Apr; 38(4):676-686. PubMed ID: 28865176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
    Zhang Y; Wang C; Li H; Ding Y
    Medicine (Baltimore); 2019 Jan; 98(3):e13929. PubMed ID: 30653099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
    Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
    Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
    Kim SU; Lee JH; Kim DY; Ahn SH; Jung KS; Choi EH; Park YN; Han KH; Chon CY; Park JY
    PLoS One; 2012; 7(5):e36676. PubMed ID: 22574212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELF-test less accurately identifies liver cirrhosis diagnosed by liver stiffness measurement in non-Asian women with chronic hepatitis B.
    Harkisoen S; Boland GJ; van den Hoek JA; van Erpecum KJ; Hoepelman AI; Arends JE
    J Clin Virol; 2014 Dec; 61(4):503-8. PubMed ID: 25467860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.